Detalles de la búsqueda
1.
Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
Cytotherapy
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38819367
2.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122325
3.
Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Biol Blood Marrow Transplant
; 24(6): 1209-1215, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474870
4.
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Br J Haematol
; 181(6): 782-790, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29741758
5.
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Biol Blood Marrow Transplant
; 21(8): 1437-44, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865648
6.
Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma.
J Clin Oncol
; 42(9): 1077-1087, 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113419
7.
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Br J Haematol
; 158(2): 174-185, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22640008
8.
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population.
Clin Lymphoma Myeloma Leuk
; 21(7): 476-482, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33814336
9.
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(5): 639-46, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20005967
10.
Day 14 Bone Marrow Evaluation During Acute Myeloid Leukemia Induction in a Real-world Canadian Cohort.
Clin Lymphoma Myeloma Leuk
; 20(7): e427-e436, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32201130
11.
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Biol Blood Marrow Transplant
; 15(2): 205-13, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19167680
12.
Outpatient Autologous Stem Cell Transplants for Multiple Myeloma: Analysis of Safety and Outcomes in a Tertiary Care Center.
Clin Lymphoma Myeloma Leuk
; 19(12): 784-790, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31678079
13.
Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Clin Lymphoma Myeloma Leuk
; 18(11): e481-e491, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30100330
14.
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.
Leuk Lymphoma
; 58(2): 324-332, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27347845
15.
Comparison of a pediatric-inspired treatment protocol versus standard-intensity chemotherapy for young adults with standard-risk BCR-ABL negative acute lymphoblastic leukemia.
Leuk Lymphoma
; 58(4): 909-915, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27561638
16.
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
J Clin Oncol
; 35(32): 3722-3733, 2017 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28898161
17.
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
Clin Lymphoma Myeloma Leuk
; 15(6): 341-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25656914
18.
High-dose Benda-EAM versus BEAM in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplantation.
Bone Marrow Transplant
; 54(3): 481-484, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171222
19.
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.
Leuk Lymphoma
; 53(7): 1321-6, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22192245
20.
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).
Leuk Lymphoma
; 52(1): 34-41, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21133716